ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Relationships between endogenous and exogenous T and CVD in men
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 237642" data-attributes="member: 13851"><p><strong>Fig. 2 <u>The benefit vs. risk ratio for testosterone-based therapies in hypogonadal men, eugonadal men, and for a prototype male hormonal contraception</u>. a For hypogonadal men, the proven benefits of testosterone replacement therapy (e.g., improved sexual function, muscle mass and strength, bone mass and strength, and overall sense of wellbeing) exceed the small potential (unproven) adverse effects on incident cardiovascular risk; b For eugonadal men who are taking testosterone therapy to increase muscle mass and strength above the level achieved with exercise, the small potential adverse effects on incident cardiovascular risk outweigh the (unproven) potential benefits; c For an effective (≥95% efficacy) androgen-based prototype male hormonal contraceptive, the benefits to the couple include agency over reproduction for the man and increased overall health safety for the couple (e.g., decreased anxiety about unwanted conceptions for the man and woman and decreased health risks associated with pregnancy and with female contraceptives for the woman). These benefits would be greater than the small potential (unproven) adverse effects on incident cardiovascular risk for the man</strong></p><p><strong>[ATTACH=full]26570[/ATTACH]</strong></p></blockquote><p></p>
[QUOTE="madman, post: 237642, member: 13851"] [B]Fig. 2 [U]The benefit vs. risk ratio for testosterone-based therapies in hypogonadal men, eugonadal men, and for a prototype male hormonal contraception[/U]. a For hypogonadal men, the proven benefits of testosterone replacement therapy (e.g., improved sexual function, muscle mass and strength, bone mass and strength, and overall sense of wellbeing) exceed the small potential (unproven) adverse effects on incident cardiovascular risk; b For eugonadal men who are taking testosterone therapy to increase muscle mass and strength above the level achieved with exercise, the small potential adverse effects on incident cardiovascular risk outweigh the (unproven) potential benefits; c For an effective (≥95% efficacy) androgen-based prototype male hormonal contraceptive, the benefits to the couple include agency over reproduction for the man and increased overall health safety for the couple (e.g., decreased anxiety about unwanted conceptions for the man and woman and decreased health risks associated with pregnancy and with female contraceptives for the woman). These benefits would be greater than the small potential (unproven) adverse effects on incident cardiovascular risk for the man [ATTACH type="full"]26570[/ATTACH][/B] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Relationships between endogenous and exogenous T and CVD in men
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top